The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 01, 2013
Filed:
May. 14, 2012
Muhammad Safadi, Nazareth, IL;
Daniella Licht, Givat Shmuel, IL;
Ioana Lovinger, Kfar-Saba, IL;
Aharon M. Eyal, Jerusalem, IL;
Tomas Fristedt, Helsingborg, SE;
Karl Jansson, Dalby, SE;
Muhammad Safadi, Nazareth, IL;
Daniella Licht, Givat Shmuel, IL;
Ioana Lovinger, Kfar-Saba, IL;
Aharon M. Eyal, Jerusalem, IL;
Tomas Fristedt, Helsingborg, SE;
Karl Jansson, Dalby, SE;
Teva Pharmaceutical Industries, Ltd., Petach-Tikva, IL;
Active Biotech, AB, Lund, SE;
Abstract
The subject invention provides a pharmaceutical composition comprising N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide or the salt thereof; a pharmaceutically acceptable carrier; and not more than 0.5% w/w relative to N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide of 2-Chloro-6-(1-ethyl-N-methyl-2-oxoindoline-3-carboxamido)benzoic acid, 1H,3H-spiro[5-chloro-1-methylquinoline-2,4-dione-3,3'-[1]ethylindolin-[2]-one], or 5-Chloro-N-ethyl-3-hydroxy-1-methyl-2,4-dioxo-N-phenyl-1,2,3,4-tetrahydro-quinoline-3-carboxamide.